O'Donnell L D, Heaton K W
University Department of Medicine, Bristol Royal Infirmary.
Gut. 1988 May;29(5):655-8. doi: 10.1136/gut.29.5.655.
One hundred patients with radiolucent gall stones less than or equal to 1.5 cm in functioning gall bladders have received oral bile acid dissolution therapy since 1975. Complete data are available on 93 who have received at least six months' treatment. The complete dissolution rate in appropriately selected patients who complied with and tolerated an adequate course of treatment was 55%. By life table analysis the recurrence rates were 13% at one year, 21% at two years, 31% at three years, and 43% at four years. Thereafter the recurrence rate levelled out, being 49% at 11 years. Redissolution was achieved in all seven patients who had a second course of therapy, but was usually followed by re-recurrence. Patients whose gall stones recurred did not differ significantly from those who remained stone free with respect to age, sex, body weight, or time required for dissolution.
自1975年以来,100例胆囊功能正常、胆囊结石透X线且直径小于或等于1.5 cm的患者接受了口服胆汁酸溶石治疗。93例接受了至少6个月治疗的患者有完整的数据。在适当选择的、依从并耐受足够疗程治疗的患者中,完全溶石率为55%。通过生命表分析,1年复发率为13%,2年为21%,3年为31%,4年为43%。此后复发率趋于平稳,11年时为49%。接受第二疗程治疗的7例患者均实现了再溶石,但通常随后又复发。结石复发的患者在年龄、性别、体重或溶石所需时间方面与结石未复发的患者没有显著差异。